LIFECORE BIOMEDICAL, INC. Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
LIFECORE BIOMEDICAL, INC. (LFCR) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 121.65 thousand shares for the 12-month period ending 2018-05-27, per its 10-K filed 2018-08-09.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2018-08-09
- LIFECORE BIOMEDICAL, INC. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2018 was 121.65K shares, a 11.26% decline from fiscal 2017.
- LIFECORE BIOMEDICAL, INC. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2017 was 137.09K shares, a 43.47% increase from fiscal 2016.
- LIFECORE BIOMEDICAL, INC. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2016 was 95.55K shares, a 15.02% decline from fiscal 2015.
- LIFECORE BIOMEDICAL, INC. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2015 was 112.44K shares, a 136.36% increase from fiscal 2014.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 12 month |
|---|---|
| 2018-05-27 | 121.65K shares 10-K · filed 2018-08-09 |
| 2017-05-28 | 137.09K shares 10-K · filed 2018-08-09 |
| 2016-05-29 | 95.55K shares 10-K · filed 2018-08-09 |
| 2015-05-31 | 112.44K shares 10-K/A · filed 2018-03-15 |
| 2014-05-25 | 47.57K shares 10-K · filed 2016-08-01 |
| 2013-05-26 | 145.16K shares 10-K · filed 2015-07-31 |
| 2012-05-27 | 326.95K shares 10-K · filed 2014-08-01 |
| 2011-05-29 | 136.37K shares 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |